Fig. 4From: Evaluation of patients treated with direct-acting anti-viral therapy for chronic hepatitis C and their risk of hepatocellular carcinoma in Hong Konga ROC curve analysis shows that the optimal cut-off level of AFP at the end of DAA therapy for predicting HCC development was 5.6 ng/mL (sensitivity 78.6%, specificity 80.5%, Area under the ROC curve = 0.864). b Cumulative incidence of HCC, stratified by the AFP level at the end of DAA therapyBack to article page